Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Ragnar Weberg"'
Publikováno v:
Cogent Medicine, Vol 3, Iss 1 (2016)
Objective: The diagnostic yield of esophagogastroduodenoscopy (EGD) depends on appropriate patient selection. The aim of the current study was to create a nomogram predicting findings with limited or no clinical implication in patients referred to EG
Externí odkaz:
https://doaj.org/article/e87d738ff6ca410592b7951a8e93ab07
Publikováno v:
Fresenius' Journal of Analytical Chemistry. 337:310-315
A method for the direct determination of aluminium in human biopsy and necropsy specimens is described. The working range of the procedure was from 0.2 to 100 mgkg−1 using clean room facilities. The detection limit of aluminium is strongly dependen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7cd2321c0c31f57265df8430edf70ae2
https://doi.org/10.1007/bf00321980
https://doi.org/10.1007/bf00321980
Publikováno v:
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke. 127(8)
A discharge summary should be sent to the primary care physicians to ensure adequate follow-up of patients after discharge from hospital. It should arrive in due time and its content should serve its purpose.We identified six criteria to be used for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0e248bd55119051f318bf89ee024cf0e
https://pubmed.ncbi.nlm.nih.gov/17457391
https://pubmed.ncbi.nlm.nih.gov/17457391
Autor:
Njaal Stray, Ragnar Weberg
Publikováno v:
Scandinavian journal of gastroenterology. 41(7)
Previous studies show conflicting results in the diagnostic yield of oesophagogastroduodenoscopy (OGD) and colonoscopy (bi-directional) in identifying potential bleeding sources (PBS) in patients investigated for occult gastrointestinal bleeding (OGI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dadb479f5d85892a8eff01647cfcb082
https://pubmed.ncbi.nlm.nih.gov/16785199
https://pubmed.ncbi.nlm.nih.gov/16785199
Autor:
Steve Holland, Arnold Berstad, Basil I. Hirschowitz, Ragnar Weberg, Arne Serck-Hanssen, Bruce Alexander
Publikováno v:
Gastroenterology. 95(3)
Antral biopsy specimens from 89 consecutive patients with nonulcer dyspepsia and erosive prepyloric changes included in a prospective, randomized, double-blind 4-wk study of the effect of an aluminum-magnesium antacid (120 mmol/day) or pirenzepine (5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07ccccce155e404c559a77fa122c5f98
https://pubmed.ncbi.nlm.nih.gov/3294081
https://pubmed.ncbi.nlm.nih.gov/3294081
Publikováno v:
Gastroenterology. 91(1)
A randomized, double-blind, placebo-controlled trial was conducted to determine the efficacy of a low-dose aluminum-magnesium antacid regimen (Link one tablet q.i.d.) (total neutralizing capacity 120 mmol HCl/day) in combination with a high- or a low
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83c073366197ab485d0386167b6f3983
https://pubmed.ncbi.nlm.nih.gov/3011583
https://pubmed.ncbi.nlm.nih.gov/3011583
Publikováno v:
Scandinavian journal of gastroenterology. 20(9)
In a double-blind, randomized, multicenter trial in 80 consecutive outpatients with endoscopically verified duodenal ulcer, we have tested the ulcer-healing efficacy of a quite low dose of antacids, given only four times daily. The patients received
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dbd007805a5c40bf5be66e301c331a70
https://pubmed.ncbi.nlm.nih.gov/3911365
https://pubmed.ncbi.nlm.nih.gov/3911365
Autor:
Arnold Berstad, Kåre R. Vetvik, Nils Hovdenak, Erik Aubert, O. J. Lange, Per G. Farup, Asbjørn Stallemo, Olav Dahlberg, Magnus Melsom, Ragnar Weberg, Jan Dybdahl, Erik Ellekjær
Publikováno v:
Europe PubMed Central
Scopus-Elsevier
Scopus-Elsevier
In a double-blind, randomized, multicenter trial 150 consecutive outpatients with endoscopically verified duodenal ulcer were treated with either a low-dose antacid regimen (1 tablet q.i.d.; acid-neutralizing capacity, 120 mmol/day), or cimetidine (8
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5606160dc0c638effb4cb67c727301a
http://europepmc.org/abstract/med/3053312
http://europepmc.org/abstract/med/3053312
Autor:
Dybdahl J, Fyllingen G, O. J. Lange, Ragnar Weberg, S. Wetterhus, Per G. Farup, Arnold Berstad, Kannelønning Ks, Dahlberg O
Publikováno v:
Europe PubMed Central
Scopus-Elsevier
Scopus-Elsevier
Ninety-one patients with reflux oesophagitis were randomly allocated to treatment with one chewable antacid tablet (acid-neutralizing capacity, 30 mmol) four times daily, 400 mg cimetidine twice daily, or placebo. The study was double-blind, with a d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cede4b58e174cb5257ecf8b774b41c3a
http://europepmc.org/abstract/med/2181623
http://europepmc.org/abstract/med/2181623